This investigation was conducted on 182 hospitalized COVID-19 patients which demonstrated a higher serum NOX2 dosage, specifically in patients who needed mechanical ventilation or with thrombosis, so suggesting a connection between NOX2 activation and clinical worsening [12]. Here, CYBB is linked to COVID-19.